PredictImmune is a developer of prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases. The company aims to develop and commercialize a series of biomarker tests to guide physicians in the treatment of patients with immune-mediated disease, through prediction of long-term clinical prognosis.
|Employees (est.) (Jul 2021)||12||(+10%)|
PredictImmune total Funding
PredictImmune latest funding size
Time since last funding
|2 years ago|
|Wellcome Trust, Business Growth Fund, University of Cambridge Enterprise, Wren Capital, Cambridge Innovation Capital, Parkwalk Advisors|
PredictImmune has 273 Twitter Followers. The number of followers has increased 0.4% month over month and increased 0.7% quarter over quarter
When was PredictImmune founded?
PredictImmune was founded in 2017.
Who are PredictImmune key executives?
PredictImmune's key executives are Paul Lyons.
How many employees does PredictImmune have?
PredictImmune has 12 employees.
Who are PredictImmune competitors?
Competitors of PredictImmune include LUMICKS, Brainsway and Fluidic Analytics.
Where is PredictImmune headquarters?
PredictImmune headquarters is located at Babraham Hall, Babraham.
Where are PredictImmune offices?
PredictImmune has offices in Babraham, Cambridge and London.
How many offices does PredictImmune have?
PredictImmune has 3 offices.
Receive alerts for 300+ data fields across thousands of companies